Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> DIABETES Latest News

JAN 08, 2013 - Yahoo! News

A Must Read - Share

FDA staff say J&J's new diabetes drug may pose heart risks

(Reuters) - A new kind of diabetes drug being developed by Johnson & Johnson raised the level of bad cholesterol in patients during clinical trials and may pose heart risks, U.S. drug reviewers said in documents published on Tuesday. J&J is testing canagliflozin to treat Type 2 diabetes, which is often associated with obesity and a lack of exercise. Diabetes affects about 370 million people worldwide, and about 90 percent of those cases are Type 2 diabetes. ...

Tags: FDA staff say J&J's new diabetes drug may pose heart risks,  Diabetes Latest News